J Fernández de Castro

Author

Also Known As

J F de Castro, J Fernandez de Castro, J Fernández de Castro, J Fernändez de Castro, J. F. de Castro, J. Fernandez de Castro, JORGE FERNANDEZ DE CASTRO, Jorge Fernandez de Castro, Jorge Fernández De Castro, Jorge Fernández de Castro

Publications

858

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Salud Pública Centers for Disease Control and Prevention Emory University Secretaria de Salud Universidad Nacional Autónoma de México

About

J Fernández de Castro is an author at Instituto Nacional de Salud Pública specializing in vaccination, medicine, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	569
2	Immunology	10	10	386
3	Public Health	1	1	11
4	Allergy	1	1	17
5	Epidemiology	1	1	11

J Fernández de Castro

Publications

789

Citations

H-Index

Page 1

	Year	Citations
Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial Athmanundh Dilraj, Felicity T. Cutts, J Fernández de Castro, The Lancet VaccinationVaccinologyVaccine SafetyVaccine DevelopmentVaccine Surveillance	2000	156
Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. John V. Bennett, J Fernández de Castro, José Luis Valdespino‐Gómez, PubMed	2002	123
Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. A. B. Sabin, Amador Flores Aréchiga, J Fernández de Castro, PubMed VaccinationVaccinologyAsthmaVaccine SafetyMaternal Antibody	1983	115
A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children Jaime Sepúlveda-Amor, José Luis Valdespino‐Gómez, John V. Bennett, Vaccine VaccinationVaccinologyVaccine DevelopmentSuccessful Boosting ResponsesImmunology	2002	66
Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine Joseph A. Bellanti, Barbara J. Zeligs, Julia Mendez-Inocencio, Vaccine VaccinationVaccinologyMucosal VaccinationVaccine DevelopmentImmunology	2003	51
Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol) J Fernández de Castro, John V. Bennett, Hector Gallardo Rincon, Vaccine VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Testing	2004	51
EPIDEMIOLOGIC INVESTIGATIONS OF DENGUE INFECTION IN MEXICO, 1980 Jonathan E. Kaplan, D. A. Eliason, Melinda Moore, American Journal of Epidemiology	1983	44
PERSISTENCE OF MEASLES ANTIBODY TWO YEARS AFTER REVACCINATION BY AEROSOL OR SUBCUTANEOUS ROUTES Athmanundh Dilraj, Felicity T. Cutts, John V. Bennett, The Pediatric Infectious Disease Journal	2000	42
Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: Comparisons with injected MMR José Luis Díaz‐Ortega, John V. Bennett, Deyanira Castaneda, Vaccine VaccinologyVaccinationAerosolized Triviraten VaccineVaccine DevelopmentInjected Mmr	2009	29
Booster immune response in children 6–7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection José Luis Díaz‐Ortega, John V. Bennett, Deyanira Castañeda-Desales, Vaccine VaccinologyVaccine SafetyVaccinationChildren 6–7Vaccine Development	2014	18

Page 1